Patents by Inventor Evangelos L. Tzanis

Evangelos L. Tzanis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 9-Aminomethyl Minocycline Compounds And Use Thereof In Treating Community-Acquired Bacterial Pneumonia (CABP)
    Publication number: 20210052609
    Abstract: The invention disclosed herein provides a method for treating Community-Acquired Bacterial Pneumonia (CABP) using 9-[(2,2-dimethyl-propyl amino)-methyl]-minocycline or a salt thereof, in either oral or IV doses or a combination of both.
    Type: Application
    Filed: November 4, 2020
    Publication date: February 25, 2021
    Applicants: Paratek Pharmaceuticals, Inc., Paratek Pharmaceuticals, Inc.
    Inventors: Evangelos L. Tzanis, Paul McGovern, Amy L. Manley, Lynne Garrity-Ryan, S. Ken Tanaka
  • 9-aminomethyl minocycline compounds and use thereof in treating community-acquired bacterial pneumonia (CABP)
    Patent number: 10835542
    Abstract: The invention disclosed herein provides a method for treating Community-Acquired Bacterial Pneumonia (CABP) using 9-[(2,2-dimethyl-propyl amino)-methyl]-minocycline or a salt thereof, in either oral or IV doses or a combination of both.
    Type: Grant
    Filed: July 10, 2019
    Date of Patent: November 17, 2020
    Assignee: Paratek Pharmaceuticals, Inc.
    Inventors: Evangelos L. Tzanis, Paul McGovern, Amy L. Manley, Lynne Garrity-Ryan, S. Ken Tanaka
  • 9-Aminomethyl Minocycline Compounds And Use Thereof In Treating Community-Acquired Bacterial Pneumonia (CABP)
    Publication number: 20200009162
    Abstract: The invention disclosed herein provides a method for treating Community-Acquired Bacterial Pneumonia (CABP) using 9-[(2,2-dimethyl-propyl amino)-methyl]-minocycline or a salt thereof, in either oral or IV doses or a combination of both.
    Type: Application
    Filed: July 10, 2019
    Publication date: January 9, 2020
    Inventors: Evangelos L. Tzanis, Paul McGovern, Amy L. Manley, Lynne Garrity-Ryan, S. Ken Tanaka
  • 9-aminomethyl minocycline compounds and use thereof in treating community-acquired bacterial pneumonia (CABP)
    Patent number: 10383884
    Abstract: The invention disclosed herein provides a method for treating Community-Acquired Bacterial Pneumonia (CABP) using 9-[(2,2-dimethyl-propyl amino)-methyl]-minocycline or a salt thereof, in either oral or IV doses or a combination of both.
    Type: Grant
    Filed: October 31, 2017
    Date of Patent: August 20, 2019
    Assignee: Paratek Pharmaceuticals, Inc.
    Inventors: Evangelos L. Tzanis, Paul McGovern, Amy L. Manley, Lynne Garrity-Ryan, S. Ken Tanaka
  • 9-AMINOMETHYL MINOCYCLINE COMPOUNDS AND METHODS OF USE THEREOF IN URINARY TRACT INFECTION (UTI) TREATMENT
    Publication number: 20190175625
    Abstract: The invention disclosed herein provides a method for treating urinary tract infection (UTI) using 9-[(2,2-dimethyl-propyl amino)-methyl]-minocycline or a salt thereof, in either oral or IV doses or a combination of both.
    Type: Application
    Filed: February 13, 2019
    Publication date: June 13, 2019
    Inventors: Amy L. Manley, Evangelos L. Tzanis, Lynne Garrity-Ryan, S. Ken Tanaka, Judith N. Steenbergen, Stephen Bai
  • 9-AMINOMETHYL MINOCYCLINE COMPOUNDS AND USES THEREOF
    Publication number: 20190125767
    Abstract: Methods and compositions for using a tetracycline compound to treat bacterial infections are described. In one embodiment, for example, the invention provides a method of treating a subject for an infection, comprising administering to said subject an effective amount of 9-[(2,2-dimethyl-propyl amino)-methyl]-minocycline or a salt thereof, such that said subject is treated, wherein the 9-[(2,2-dimethyl-propyl amino)-methyl]-minocycline is administered orally at a dose of about 450 mg per day for two consecutive days, then at a dose of about 300 mg per day for 5 or more days.
    Type: Application
    Filed: September 24, 2018
    Publication date: May 2, 2019
    Inventors: S. Ken Tanaka, Evangelos L. Tzanis, Lynne Garrity-Ryan, Amy L. Manley
  • 9-aminomethyl minocycline compounds and methods of use thereof in urinary tract infection (UTI) treatment
    Patent number: 10238670
    Abstract: The invention disclosed herein provides a method for treating urinary tract infection (UTI) using 9-[(2,2-dimethyl-propyl amino)-methyl]-minocycline or a salt thereof, in either oral or IV doses or a combination of both.
    Type: Grant
    Filed: May 2, 2017
    Date of Patent: March 26, 2019
    Assignee: Paratek Pharmaceuticals, Inc.
    Inventors: Amy L. Manley, Evangelos L. Tzanis, Lynne Garrity-Ryan, S. Ken Tanaka, Judith N. Steenbergen, Stephen Bai
  • 9-aminomethyl minocycline compounds and uses thereof
    Patent number: 10111890
    Abstract: Methods and compositions for using a tetracycline compound to treat bacterial infections are described. In one embodiment, for example, the invention provides a method of treating a subject for an infection, comprising administering to said subject an effective amount of 9-[(2,2-dimethyl-propyl amino)-methyl]-minocycline or a salt thereof, such that said subject is treated, wherein the 9-[(2,2-dimethyl-propyl amino)-methyl]-minocycline is administered orally at a dose of about 450 mg per day for two consecutive days, then at a dose of about 300 mg per day for 5 or more days.
    Type: Grant
    Filed: August 3, 2017
    Date of Patent: October 30, 2018
    Assignee: Paratek Pharmaceuticals, Inc.
    Inventors: S. Ken Tanaka, Evangelos L. Tzanis, Lynne Garrity-Ryan, Amy L. Manley
  • 9-Aminomethyl Minocycline Compounds And Use Thereof In Treating Community-Acquired Bacterial Pneumonia (CABP)
    Publication number: 20180153908
    Abstract: The invention disclosed herein provides a method for treating Community-Acquired Bacterial Pneumonia (CABP) using 9-[(2,2-dimethyl-propyl amino)-methyl]-minocycline or a salt thereof, in either oral or IV doses or a combination of both.
    Type: Application
    Filed: October 31, 2017
    Publication date: June 7, 2018
    Applicant: Paratek Pharmaceuticals, Inc.
    Inventors: Evangelos L. Tzanis, Paul McGovern
  • 9-AMINOMETHYL MINOCYCLINE COMPOUNDS AND USES THEREOF
    Publication number: 20180055859
    Abstract: Methods and compositions for using a tetracycline compound to treat bacterial infections are described. In one embodiment, for example, the invention provides a method of treating a subject for an infection, comprising administering to said subject an effective amount of 9-[(2,2-dimethyl-propyl amino)-methyl]-minocycline or a salt thereof, such that said subject is treated, wherein the 9-[(2,2-dimethyl-propyl amino)-methyl]-minocycline is administered orally at a dose of about 450 mg per day for two consecutive days, then at a dose of about 300 mg per day for 5 or more days.
    Type: Application
    Filed: August 3, 2017
    Publication date: March 1, 2018
    Applicant: Paratek Pharmaceuticals, Inc.
    Inventors: S. Ken Tanaka, Evangelos L. Tzanis, Lynne Garrity-Ryan, Amy L. Manley
  • 9-AMINOMETHYL MINOCYCLINE COMPOUNDS AND METHODS OF USE THEREOF IN URINARY TRACT INFECTION (UTI) TREATMENT
    Publication number: 20170333455
    Abstract: The invention disclosed herein provides a method for treating urinary tract infection (UTI) using 9-[(2,2-dimethyl-propyl amino)-methyl]-minocycline or a salt thereof, in either oral or IV doses or a combination of both.
    Type: Application
    Filed: May 2, 2017
    Publication date: November 23, 2017
    Applicant: Paratek Pharmaceuticals, Inc.
    Inventors: Amy L. Manley, Evangelos L. Tzanis, Lynne Garrity-Ryan, S. Ken Tanaka